• slider1

Company Overview

Insilicomed develops and licenses state of the art cardiovascular simulation technology. Based on more than 25 years of scientific research led by the company’s founders, we are able to accurately simulate the time-varying electrical and mechanical function of the heart in health and disease including:

Cardiovascular simulation of Ventricular Model indicating arrhythmia

  • Ventricular hypertrophy
  • Heart failure
  • Myocardial infarction
  • Heart valve disease
  • Cardiac electrical arrhythmias

These realistic and complex in silico simulations help medical device designers visualize and understand how their devices will behave in a realistic environment in vivo. Insilicomed clients are able to:
cardiovascular simulation compared to X-ray image

  • Reduce development time and cost
  • Create more realistic bench testing
  • Develop more effective prototypes
  • Eliminate or reduce the size of costly
    large animal studies

Insilicomed is currently focused on patient-specific clinical applications in heart disease with an emphasis on heart failure (HF). Detailed methods have been developed to correlate standard clinical data with pre-treatment HF simulations of individual patient cardiac function. These predictive simulations will be used by clinicians to optimize diagnosis and treatment, increasing patient benefit and reducing the large number of non-responders to widely-used and expensive treatments, such as CRT.

Design by Sagemont